{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fhdv-in-2022-YU8ioDMf","width":444,"version":"1.0","type":"rich","title":"Hepatitis Delta a Major Global Problem: Screening, Diagnosis, and Treatment in 2022 – Physician Discussion #1","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/581c59c8-21c7-48f4-96ca-0d71c0c16718/key-challenges-ct-podcast-6-icon-1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/447594c8-1558-4b39-8c6f-70d06c2e7523\" height=\"200\" width=\"100%\" title=\"Hepatitis Delta a Major Global Problem: Screening, Diagnosis, and Treatment in 2022 – Physician Discussion #1\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast, CCO’s expert faculty discusses HDV epidemiology beyond the United States, the features of HDV/HBV pathology, insights into screening and diagnostic approaches, key aspects of disease staging, new treatment options, and important remaining clinical questions regarding optimal management of HDV."}